Target intelligence / Profile preview

Diaphanous-related formin 1 (mDia1)

Target
mDia1
Molecular classification
Actin regulator, Rho effector protein, Formin family protein, Cytoskeletal protein
01

Overview

Diaphanous-related formin 1 (mDia1) is a member of the formin protein family and acts as a key regulator of the actin cytoskeleton in eukaryotic cells. It functions as an effector for Rho GTPases and is essential for actin filament nucleation, elongation, and organization. mDia1 forms dimers that processively cap growing actin filaments and is autoinhibited by intramolecular interaction between its N-terminal and C-terminal domains, a process relieved by Rho GTPase binding. Through these activities, mDia1 is critical in cellular processes such as stress fiber and filopodia formation, cytokinesis, cell migration, and cellular response to extracellular signals. It also contributes to phagocytosis and microtubule stabilization, and through regulation of actin dynamics, indirectly modulates transcription via serum response factor (SRF) activation. Dysregulation of mDia1 has implications in cancer and development due to its control of cytoskeletal remodeling and cell movement.

Other names
Dia1Drf1Diaph1KIAA4062p140mDiamKIAA4062D18Wsu154e
02

Mechanism of action

Actin nucleation by interaction with barbed ends of actin filaments Relief of autoinhibition through Rho GTPase binding, promoting actin assembly

03

Biological functions

Actin nucleation and polymerizationStress fiber formationFilopodia formationCytokinesisCell migrationPhagocytosisMicrotubule stabilizationSerum response factor (SRF) transcriptional activity
04

Disease associations

Cancer (linked to cell migration, cytoskeletal remodeling)Other (general roles in development and morphogenesis)
05

Safety considerations

No target-specific safety concerns or clinical therapeutic challenges reported in available sources

Beyond the preview

Go deeper on Diaphanous-related formin 1 (mDia1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diaphanous-related formin 1 (mDia1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call